These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 7502701

  • 1. Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women.
    Kohrt WM, Snead DB, Slatopolsky E, Birge SJ.
    J Bone Miner Res; 1995 Sep; 10(9):1303-11. PubMed ID: 7502701
    [Abstract] [Full Text] [Related]

  • 2. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.
    Milliken LA, Going SB, Houtkooper LB, Flint-Wagner HG, Figueroa A, Metcalfe LL, Blew RM, Sharp SC, Lohman TG.
    Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871
    [Abstract] [Full Text] [Related]

  • 3. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women.
    Maddalozzo GF, Widrick JJ, Cardinal BJ, Winters-Stone KM, Hoffman MA, Snow CM.
    Bone; 2007 May; 40(5):1244-51. PubMed ID: 17291843
    [Abstract] [Full Text] [Related]

  • 4. Effects of exercise involving predominantly either joint-reaction or ground-reaction forces on bone mineral density in older women.
    Kohrt WM, Ehsani AA, Birge SJ.
    J Bone Miner Res; 1997 Aug; 12(8):1253-61. PubMed ID: 9258756
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C, Dane B, Cetin A, Erginbas M.
    Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
    [Abstract] [Full Text] [Related]

  • 6. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M, Ciaponi M, Cappagli B, Genazzani AR.
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [Abstract] [Full Text] [Related]

  • 7. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M, Cappagli B, Ciaponi M, Pepe A, Vacca F, Genazzani AR.
    Maturitas; 2008 Jan 20; 59(1):2-6. PubMed ID: 18063490
    [Abstract] [Full Text] [Related]

  • 8. Effects of isoflavone and exercise on BMD and fat mass in postmenopausal Japanese women: a 1-year randomized placebo-controlled trial.
    Wu J, Oka J, Tabata I, Higuchi M, Toda T, Fuku N, Ezaki J, Sugiyama F, Uchiyama S, Yamada K, Ishimi Y.
    J Bone Miner Res; 2006 May 20; 21(5):780-9. PubMed ID: 16734394
    [Abstract] [Full Text] [Related]

  • 9. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
    Armamento-Villareal RC, Napoli N, Klug T, Civitelli R.
    Bone; 2004 Sep 20; 35(3):682-8. PubMed ID: 15336604
    [Abstract] [Full Text] [Related]

  • 10. Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women.
    Chen JT, Hosoda K, Hasumi K, Ogata E, Shiraki M.
    J Bone Miner Res; 1996 Nov 20; 11(11):1784-92. PubMed ID: 8915787
    [Abstract] [Full Text] [Related]

  • 11. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
    Kim JG, Kim JH, Lee DO, Kim H, Kim JY, Suh CS, Kim SH, Choi YM.
    Menopause; 2008 Nov 20; 15(2):357-62. PubMed ID: 17925661
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 20; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hormone replacement therapy increases trabecular and cortical bone density in osteoporotic women.
    Bagur A, Wittich A, Ghiringhelli G, Vega E, Mautalen C.
    Medicina (B Aires); 1996 Jan 20; 56(3):247-51. PubMed ID: 9035480
    [Abstract] [Full Text] [Related]

  • 18. Pre- and postmenopausal women have different bone mineral density responses to the same high-impact exercise.
    Bassey EJ, Rothwell MC, Littlewood JJ, Pye DW.
    J Bone Miner Res; 1998 Dec 20; 13(12):1805-13. PubMed ID: 9844097
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist and total body in late postmenopausal women.
    Kohrt WM, Birge SJ.
    Osteoporos Int; 1995 May 20; 5(3):150-5. PubMed ID: 7655174
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.